First IL-17 Inhibitor Approved in Europe for HS Patients First IL-17 Inhibitor Approved in Europe for HS Patients
The European Commission has approved the first interleukin-17A inhibitor for treating hidradenitis suppurativa.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2023 Category: Consumer Health News Tags: Dermatology News Alert Source Type: news
Cryopreserved Human Allograft in Hidradenitis Suppurativa Cryopreserved Human Allograft in Hidradenitis Suppurativa
This case report describes the use of a cryopreserved human allograft in the treatment of a patient with severe hidradenitis suppurativa.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2023 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
AAD: Promising Results Seen for Bimekizumab in Hidradenitis Suppurativa
WEDNESDAY, March 29, 2023 -- For patients with moderate-to-severe hidradenitis suppurativa (HS), bimekizumab shows promise in phase 3 trials, according to research presented at the annual meeting of the American Academy of Dermatology, held from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2023 Category: Pharmaceuticals Source Type: news
Studies Validate IL-17 as Hidradenitis Suppurativa Drug Target Studies Validate IL-17 as Hidradenitis Suppurativa Drug Target
Two phase 3 studies with the IL-17 inhibitor bimekizumab for moderate-to-severe hidradenitis suppurativa generate clinically meaningful results, researchers report.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 20, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
Response Rates in Hidradenitis Suppurativa Continue to Climb With New Therapies
(MedPage Today) -- NEW ORLEANS -- A trio of novel therapies produced clinically significant improvements in 40% to 70% of patients with moderate to severe hidradenitis suppurativa (HS), according to data reported here.
Izokibep, a novel interleukin... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 20, 2023 Category: Dermatology Source Type: news
Secukinumab Shows Benefit for Hidradenitis Suppurativa at 1 Year Secukinumab Shows Benefit for Hidradenitis Suppurativa at 1 Year
Currently, the tumor necrosis factor inhibitor adalimumab is the only biologic therapy approved for the treatment of moderate to severe hidradenitis suppurativa.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 14, 2023 Category: Dermatology Tags: Dermatology News Source Type: news
Parascapular Flap for Axillary Defect Reconstruction Parascapular Flap for Axillary Defect Reconstruction
The authors describe the use of the propeller parascapular flap in patients with advanced hidradenitis suppurativa who underwent axillary defect reconstruction after resection.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2022 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
Brepocitinib Improves Mild to Moderate AD in Phase 2b Trial Brepocitinib Improves Mild to Moderate AD in Phase 2b Trial
In addition to AD, brepocitinib, a topical TYK2/JAK1 inhibitor, is being developed as a treatment for dermatomyositis, SLE, hidradenitis suppurativa, and non-infectious uveitis.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 29, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Medicaid Coverage of HPV Vaccine: Implications in Dermatology Medicaid Coverage of HPV Vaccine: Implications in Dermatology
Adults with dermatologic conditions such as hidradenitis suppurativa"may be at increased risk for persistent and high-risk HPV infection" and may benefit from HPV vaccination, study authors said.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2022 Category: Consumer Health News Tags: Dermatology News Source Type: news
What Causes Anal Itching?
Discussion
Pinworms are caused by the parasite Enterobius vermicularis. Humans are the only known reservoir and are infected by fecal-oral transmission of eggs or indirectly such as through contaminated clothing or bedding. It is commonly seen in children and can easily pass to family members, plus people can become easily reinfected. The incubation period is usually 1-2 months and eggs can survive outside humans for 2-3 weeks. Adult worms migrate at night from the anus to the perianal skin and vulvar areas causing anal or vulvar itching. The itching can cause sleep problems and scratching can cause secondary bacterial inf...
Source: PediatricEducation.org - October 31, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Hope Shines Bright for Hidradenitis Suppurativa Treatments Hope Shines Bright for Hidradenitis Suppurativa Treatments
Secukinumab and the investigational drug brepocitinib were shown to alleviate the effects of the chronic and painful skin condition in separate, unrelated trials.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 16, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Does Hidradenitis Suppurativa Worsen During Pregnancy Does Hidradenitis Suppurativa Worsen During Pregnancy
The highest prevalence of HS is among people in their 20s and 30s, so clinicians are likely to encounter female patients with HS who are either pregnant or actively thinking about getting pregnant.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 12, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Study Looks at Most Common Features of HS in Pediatric Patients Study Looks at Most Common Features of HS in Pediatric Patients
Investigators evaluated the most common clinical features, sites of involvement, and comorbidities in a series of pediatric patients with hidradenitis suppurativa.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - July 14, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
JAK1 Inhibitor INCB054707 for Hidradenitis Suppurativa JAK1 Inhibitor INCB054707 for Hidradenitis Suppurativa
Review the safety and efficacy findings from two phase II studies for the JAK1 inhibitor INCB054707 in the treatment of moderate-to-severe hidradenitis suppurativa.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 20, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Dermal Regeneration Template in Hidradenitis Reconstruction Dermal Regeneration Template in Hidradenitis Reconstruction
Patients who underwent axillary hidradenitis reconstruction with a dermal regeneration template and skin grafting realized complete healing with no complications.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 22, 2022 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
